IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2888
Positioning
Market Dominance
Services
Business Services
$3M
Maria Zannes
bioAffinity Technologies, Inc. is a privately held company incorporated in Delaware addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment. Our principal executive office is located at 22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257, and our telephone number at that address is (210) 698-5334. Our laboratory diagnostic and therapeutic research is conducted at The Harvey Sandler Cancer Research Laboratories, which is located at Science Research Laboratories, Suite 1.424, University of Texas at San Antonio, San Antonio, Texas.
Headcount
10
HQ Base
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = BIAF ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$BIAF bioAffinity Technologies, Inc. | 45 | 38 | 22 | 76 | - | - | -154.7% | -119.3% | 100.0% | -145.6% | -224.5% | -39.7% | 0.0% | 30.0x | $3M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
bioAffinity Technologies, Inc. (BIAF) receives a "Reduce" rating with a composite score of 44.5/100. It ranks #2888 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Pending Verification
Outperforming peers — winners tend to keep winning over 3-12 months
Expensive relative to fundamentals — limited margin of safety
Average quality profile
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for BIAF.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 38 | 30 | +8ALPHA |
| MOMENTUM | 76 | 85 | -9DRAG |
| VALUATION | 22 | 12 | +10ALPHA |
| INVESTMENT | 36 | 57 | -21DRAG |
| STABILITY | 6 | 2 | +4NEUTRAL |
| SHORT INT | 76 | 89 | -13DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -154.7% (sector 5.7%)
GM 100% vs sector 65%, OM -146% vs sector 5%
Capital turnover N/A, R&D intensity 22.1%
Rev growth -40%, 4yr history
Interest coverage -427.9x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate bioAffinity Technologies, Inc. (BIAF) as a Reduce with a composite score of 44.5/100 at a current price of $1.09. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential.
bioAffinity Technologies, Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 44.5/100 places it at rank #2888 in our full universe.
The near-term outlook is constructive, with revenue growing at -40% and momentum in the 76th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
No Moat
Very High
Poor
Fair Value
Gross margins of 100% signal strong pricing power.
Positive momentum indicates institutional accumulation.
Stable competitive position in a defensive sector.
Vulnerability to macroeconomic shocks and interest rate volatility.
bioAffinity Technologies, Inc. represents a reduce based on multi-factor quantitative performance.
bioAffinity Technologies, Inc. receives a Reduce rating from our analysis, with a composite score of 44.5/100 and 2 out of 5 stars, ranking #2888 out of 7,333 stocks. BIAF's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
BIAF's quality score of 38/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -154.7% (sector avg: 5.7%), gross margins of 100.0% (sector avg: 64.6%), net margins of -224.5% (sector avg: 2.8%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
BIAF registers a value score of just 22/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 0.55x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
bioAffinity Technologies, Inc.'s investment score of 36/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -39.7% vs. a sector average of 8.6% and a return on assets of -119.3% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
BIAF shows strong momentum characteristics with a score of 76/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at -39.7% year-over-year, while a beta of 3.39 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
bioAffinity Technologies, Inc. registers a low stability score of 6/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 3.39 and a debt-to-equity ratio of 30.00x (sector avg: 0.3x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
BIAF carries a short interest score of 76/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include high market sensitivity (beta: 3.39), elevated leverage (D/E: 30.00x), micro-cap liquidity risk. At $3M market cap (micro-cap), bioAffinity Technologies, Inc. offers reasonable institutional liquidity.
bioAffinity Technologies, Inc. is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #2888 of 7,333 overall (61st percentile). Key comparisons include ROE of -154.7% trailing the 5.7% sector median and operating margins of -145.6% below the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While BIAF currently exhibits a REDUCE profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (6) would have the largest impact on the composite score.
ROE 2795% BELOW SECTOR MEDIAN
Gross Margin 55% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 3336% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Kidpik Corp. (NASDAQ: PIK) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares surged 149% to $2.6450. TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share. Fangdd Network Group Ltd. (NASDAQ: DUO) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. GDS Holdings Limited (NASDAQ: GDS) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business. Solidion Technology Inc. (NASDAQ: STI) rose 23.3% to $0.9620. Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024. EHang Holdings Limited (NASDAQ: EH) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024. Bally's Corporation (NYSE: BALY) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company. Rail Vision Ltd. (NASDAQ: RVSN) climbed 21.2% to $3.43. Rail Vision ...
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. United Natural Foods posted adjusted earnings of 7 cents per share, compared to market estimates for a loss of 1 cent per share. The company’s quarterly sales came in at $7.78 billion, versus expectations of $7.87 billion, according to data from Benzinga Pro. United Natural Foods named Giorgio Matteo Tarditi as President and Chief Financial Officer. United Natural Foods shares dipped 15.2% to $12.61 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 115.2% to $4.24. Rail Vision announced first commercial installation of its AI-driven main line systems in a national railways line. Aptorum Group Limited (NASDAQ: APM) shares climbed 90.1% to $3.1750. Aptorum Group announced an agreement and plan of merger with YOOV Group Holding Ltd and a split-off agreement to separate its legacy business. NKGen Biotech, Inc. (NASDAQ: NKGN) gained 46.5% to $1.35. TRxADE HEALTH, Inc. (NASDAQ: MEDS) rose 39.2% to $11.19 after the company announced a special cash dividend of $8 per share. Airship AI Holdings, Inc. (NASDAQ: AISP) shares climbed 37.8% to $6.82. Airship AI Holdings shares jumped 200% on Tuesday after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform. Enviva Inc. (NYSE: EVA) rose 33% to $0.9854 after gaining 42% on Tuesday. American Public Education, Inc. (NASDAQ: APEI) gained 31.8% to $14.99 following upbeat quarterly results. Dada Nexus Limited (NASDAQ: DADA) climbed 30.6% to $2.5740. Dada Nexus said certain revenues and associated costs were overstated in past financial statements. Cemtrex, Inc. (NASDAQ: CETX) gained 30% to $4.4361. Cemtrex announced beta release of pioneering AI gun detection feature. Wave Life Sciences Ltd. (NYSE: WVE) gained 28.5% to $6.16 following upbeat quarterly results. Vincerx Pharma, Inc. (NASDAQ: VINC) shares gained 24.5% to $6.89. Vincerx will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024. XORTX Therapeutics Inc. (NASDAQ: XRTX) rose 24.2% to $5.85. CareMax, Inc. (NASDAQ: CMAX) gained 23.8% to ...
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company’s quarterly sales came in at $17.05 million, missing estimates of $17.33 million. SOPHiA GENETICS shares tumbled 19% to $4.55 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) climbed 146.3% to $0.1106 after dipping 19% on Monday. Sunshine Biopharma recently announced closing of $10.0 million underwritten public offering. Airship AI Holdings, Inc. (NASDAQ: AISP) climbed 93.3% to $3.16 after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform. Bruush Oral Care Inc. (NASDAQ: BRSH) surged 42.9% to $0.0686. Apogee Therapeutics, Inc. (NASDAQ: APGE) shares jumped 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results. Dave Inc. (NASDAQ: DAVE) gained 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results. CareMax, Inc. (NASDAQ: CMAX) rose 38.1% to $10.65. Enviva Inc. (NYSE: EVA) gained 26.4% to $0.6571. AeroVironment, Inc. (NASDAQ: AVAV) shares surged 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million. INNOVATE Corp. (NASDAQ: VATE) rose 24.4% to $0.90. The company reported fourth quarter financial results. Ocean Biomedical, Inc. (NASDAQ: OCEA) climbed 24.3% to $5.07. Paymentus Holdings, Inc. (NYSE: PAY) rose gained 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results. BeyondSpring Inc. (NASDAQ: BYSI) gained 20.1% to $1.97. bioAffinity Technologies, Inc. (NASDAQ: BIAF) climbed 19.4% to $2.83. bioAffinity Technologies reported accelerating sales growth of CyPath® Lung. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 18.4% to $4.18. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) ...
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) gained 73% to $0.4853. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution. Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares surged 64% to $1.6601. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine. Jin Medical International Ltd.(NASDAQ: ZJYL) climbed 49.2% to $151.96 after jumping around 264% on Monday. ProSomnus, Inc. (NASDAQ: OSA) gained 27.6% to $0.8017. ProSomnus announced data published by Cureus Journal of Medical Science showed successful treatment of obstructive sleep apnea with prosomnus precision oral appliance devices. Infobird Co., Ltd (NASDAQ: IFBD) shares gained 27.4% to $1.7266 after the company inked a new business cooperation in software development of information technology system. MIND Technology, Inc. (NASDAQ: MIND) rose 23.1% to $5.86. Yoshiharu Global Co. (NASDAQ: YOSH) rose 21.1% to $6.20. Optex Systems Holdings, Inc (NASDAQ: OPXS) gained 18.2% to $4.86. Sunnova Energy International Inc. (NASDAQ: NOVA) jumped 16.3% to $15.32. Piper Sandler upgraded Sunnova Energy Intl from Neutral to Overweight and raised the price target from $13 to $26. Cipher Mining Inc. (NASDAQ: CIFR) rose 16% to $3.6450. LogicMark, Inc. (NASDAQ:
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively. Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares climbed 73.6% to $0.3230 after the company announced it executed strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers. Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares climbed 39.7% to $6.72. Histogen Inc. (NASDAQ: HSTO) gained 27% to $0.6350. Pixelworks, Inc. (NASDAQ: PXLW) gained 22% to $1.3100 after reporting preliminary revenue results for the third quarter. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares rose 18.5% to $0.2016 after falling 15% on Tuesday. Brainstorm Cell Therapeutics recently announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS. BranchOut Food Inc. (NASDAQ: BOF) gained 16% to $2.0873. BranchOut pre-announced third-quarter revenue of roughly $1.1 million. KWESST Micro Systems Inc. (NASDAQ: KWE) climbed 13% to $1.82. Air Industries Group (NYSE: AIRI) gained 13% to $3.2699. LightPath Technologies, Inc. (NASDAQ: LPTH) climbed 11.2% to $1.59. Globus Maritime Limited (NASDAQ: GLBS) shares climbed 10.1% to $0.2439. Globus Maritime regained compliance with NASDAQ's minimum closing bid price. Star Equity Holdings, Inc. (NASDAQ: STRR) gained 9.8% to $1.0105. Accuray Incorporated (NASDAQ: ARAY) climbed 9.8% to $2.85. Accuray announced approval of the Tomo C radiation treatment delivery system by the Chinese National Medical Products Administration. CalAmp Corp. (NASDAQ: CAMP) shares jumped 9.3% to $0.4490. CalAmp is expected to release its fiscal 2024 second quarter financial results on Oct. 5, 2023. FLJ Group Limited (NASDAQ: